Sign in
4

Changes in Ownership

Faeth Therapeutics, Inc. Filed Acc 0002111813-26-000012

Options or other derivatives

  • President and CEO acquired 398,018 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Parikh Anand Kiran · President and CEO

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-07-21 Grant or award : show line 1 in the form Performance-Based Stock Option (right to buy) +398,018 398,018 D
Loading xslF345X06/form4-07232026_040701.xml…